AJDRAJNR - American Journal of Neuroradiology

Published ahead of print on November 11, 2008
doi: 10.3174/ajnr.A1385
This Article
Free to Access This article has been Unlocked
Right arrow Abstract
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Popa, R.I.
Right arrow Articles by Kallmes, D.F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Popa, R.I.
Right arrow Articles by Kallmes, D.F.

Urinary Tract Infections in the Potential Vertebroplasty Patient: Incidence, Significance, and Management

R.I. Popaa, L.A. Grayb and D.F. Kallmesb

a Department of Hospital Internal Medicine, Mayo Clinic, Rochester, Minn
b Department of Radiology, Mayo Clinic, Rochester, Minn


Figure 1
View larger version (20K):
[in this window]
[in a new window]

  		Fig 1. Algorithm for evaluation of patients considered for vertebroplasty (VP). *Dysuria, urine frequency, hematuria, urgency, and suprapubic discomfort. See text for UTI symptoms in the geriatric population. {dagger}See Table 2. {ddagger}Start treatment with trimethoprim/sulfamethoxazole 160/800 twice a day (BID) or fluoroquinolone and be guided by sensitivities obtained from urine culture. The duration of treatment is 7–14 days. §Trimethoprim/sulfamethoxazole 160/800 BID is the first-line treatment. Trimethoprim alone, fluoroquinolones for 3 days, or nitrofurantoin for 5–7 days is an alternative option. U/A indicates urine analysis; Pos., positive; Neg, negative.





Copyright © 2009 by the American Society of Neuroradiology. Print ISSN: 0195-6108 Online ISSN: 1936-959X